Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01589679 · ClinicalTrials.gov registry record · NA
Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial
A NA study, sponsored by Dynasplint Systems.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01589679 is a NA study that was terminated before completion, run by Dynasplint Systems. The registered enrollment target is 40 participants.
The verdict
NCT01589679, a NA study, was terminated before completion, sponsored by Dynasplint Systems.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
To determine the efficacy of Metatarsal Dynasplint Sytem (MTP) in reducing contracture of hallux limitus secondary to Bunionectomy, in a longitudinal, controlled trial.
Interventions
- OTHER standard of care
- DEVICE Metarsal Dynasplint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01589679
The ClinicalTrials.gov registry entry for NCT01589679 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dynasplint Systems, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which standard of care is the first listed.
NCT01589679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01589679 about?
NCT01589679 is a clinical study titled "Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial". To determine the efficacy of Metatarsal Dynasplint Sytem (MTP) in reducing contracture of hallux limitus secondary to Bunionectomy, in a longitudinal, controlled trial.
What is the current status of trial NCT01589679?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2012-04.
What interventions are being tested in trial NCT01589679?
The interventions under investigation include: standard of care (OTHER), Metarsal Dynasplint (DEVICE).
Who is sponsoring clinical trial NCT01589679?
This trial is sponsored by Dynasplint Systems, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.